Drug Type Small molecule drug |
Synonyms DRF-0529, UB-941 |
Target |
Action inhibitors |
Mechanism BRAF inhibitors(Serine/threonine-protein kinase B-raf inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | IND Application | Taiwan Province | 30 Jan 2022 | |
Lung Cancer | IND Application | Taiwan Province | 30 Jan 2022 | |
Melanoma | IND Application | Taiwan Province | 30 Jan 2022 | |
Ovarian Cancer | IND Application | Taiwan Province | 30 Jan 2022 | |
Thyroid Cancer | IND Application | Taiwan Province | 30 Jan 2022 |